Aim, Mission and Implementation
Aim, Mission and Implementation We seek to create an international academic research institute that advances scientific understanding of the disorders of gut-brain interaction, and the aims and implementation process can be found in Table 1. Through a gradual increase in the number, scope, and types of projects, as well as the number of centers involved in the projects, the Rome Foundation will advance the Research Institute to become the global leader in Disorders of the Gut-Brain Interaction (DGBI, formerly FGID) research. The Rome Foundation can provide best opportunity for achieving these goals also by actively collaborating with Industry, and other academic non-Rome stakeholders and funding agencies.
Overall structure of RFRI
The RFRI is coordinated by an Executive Committee, consisting of Dr. Magnus Simren, the Research Director and Drs. Douglas Drossman and Jan Tack. This Executive Committee with the advice of the Research Advisory Committee and Industry Council, will be ultimately responsible for assuring that the aims and objectives of the program are achieved. Under the direction of the Executive Committee and Research Advisory Committee and Industry Council, all projects with be implemented through the RFRI cores. The activity of the Cores will be determined by the ongoing and expected activities and workload within the RFRI, and their composition may vary accordingly (Figure 1). Three of the cores (“Biometry, Data Management, and Analysis,” “Clinical Research Network Core,” and “Biobank and Biomarker Data Core”) will be actively involved in specific aspects of protocol development and implementation, and as a consequence.
Rome Foundation Research Institute Executive Committee
Magnus Simrén, MD, PhD
Johannah Ruddy, M.Ed
Executive Director and RFRI Administrator
Iram Haq, MPH
Rome Research Institute, Research Assistant
The Rome Foundation Research Institute would like to thank Ironwood Pharmaceuticals and Takeda Pharmaceuticals for their sponsorship support.